Within the spectrum of RP-related retinal dystrophy, several gene therapy studies have been published for the replacement of specific mutated genes, such as RPGR MERTK, RLBP1 and PDE6B [27]. This evidence concerns the gene RLBP1 and retinitis pigmentosa 1.